Improving Access to High-Quality Sarcoma Care: Practical Delivery Models to Reduce Delays, Disparities, and Financial Toxicity

Sarcomas are rare malignancies encompassing more than 100 histologic subtypes.Their complexity demands specialized and multidisciplinary expertise that is difficult for many patients to access.Diagnostic delays, structural disparities, and significant financial toxicity collectively impede timely and attainable access to high-quality care.This narrative review synthesizes published literature on barriers to high-quality sarcoma care delivery and evaluates emerging solutions designed to address them, including hub-and-spoke networks, coordinated specialist review panels, telemedicine, and community provider education.Relevant publications were identified through PubMed and Google Scholar searches; epidemiologic data was drawn from publicly available national databases including the National Cancer Institute Surveillance, Epidemiology, and End Results Program (SEER) and the National Cancer Institute National Childhood Cancer Registry (NCCR).Meaningful improvement in sarcoma outcomes will require not only therapeutic advances, but also a deliberate redesign of how care is delivered: standardized referral pathways, expanded multidisciplinary infrastructure, and improved support to receive specialized expertise.As a rare and heterogeneous disease, sarcoma offers a valuable perspective towards the broader challenges in oncologic care delivery.binaytara.org/journal